211 related articles for article (PubMed ID: 26371951)
1. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
Nattel S; Dobrev D
J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
[No Abstract] [Full Text] [Related]
2. Novel K+ Channel Targets in Atrial Fibrillation Drug Development--Where Are We?
El-Haou S; Ford JW; Milnes JT
J Cardiovasc Pharmacol; 2015 Nov; 66(5):412-31. PubMed ID: 25978691
[TBL] [Abstract][Full Text] [Related]
3. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
Aguilar M; Nattel S
J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
[TBL] [Abstract][Full Text] [Related]
4. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
Hanley CM; Robinson VM; Kowey PR
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819
[No Abstract] [Full Text] [Related]
5. Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy.
Diness JG; Bentzen BH; Sørensen US; Grunnet M
J Cardiovasc Pharmacol; 2015 Nov; 66(5):441-8. PubMed ID: 25830485
[TBL] [Abstract][Full Text] [Related]
6. Medical management of atrial fibrillation: future directions.
Page RL
Heart Rhythm; 2007 Mar; 4(3 Suppl):S91-4. PubMed ID: 17336894
[TBL] [Abstract][Full Text] [Related]
7. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
Anderson ME
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
[No Abstract] [Full Text] [Related]
8. Novel anti-arrhythmic drugs for atrial fibrillation management.
Ehrlich JR; Nattel S; Hohnloser SH
Curr Vasc Pharmacol; 2007 Jul; 5(3):185-95. PubMed ID: 17627562
[TBL] [Abstract][Full Text] [Related]
9. First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation.
Podd SJ; Freemantle N; Furniss SS; Sulke N
Europace; 2016 Mar; 18(3):340-6. PubMed ID: 26462707
[TBL] [Abstract][Full Text] [Related]
10. Modulation of spiral wave reentry by K(+) channel blockade.
Honjo H; Yamazaki M; Kamiya K; Kodama I
Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.
Barekatain A; Razavi M
Tex Heart Inst J; 2012; 39(4):532-4. PubMed ID: 22949771
[No Abstract] [Full Text] [Related]
12. [2010 AIAC Guidelines for the management and treatment of atrial fibrillation].
Raviele A; Disertori M; Alboni P; Bertaglia E; Botto G; Brignole M; Cappato R; Capucci A; Del Greco M; De Ponti R; Di Biase M; Di Pasquale G; Gulizia M; Lombardi F; Themistoclakis S; Tritto M;
G Ital Cardiol (Rome); 2011 Jan; 12(1 Suppl 1):7-69. PubMed ID: 22624161
[No Abstract] [Full Text] [Related]
13. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
Neumann T; Hölschermann H
Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
[No Abstract] [Full Text] [Related]
14. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
15. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.
Nattel S; Sager PT; Hüser J; Heijman J; Dobrev D
Cardiovasc Res; 2021 Jun; 117(7):1616-1631. PubMed ID: 33769493
[TBL] [Abstract][Full Text] [Related]
16. New concepts in the therapy of atrial fibrillation.
Cocco G; Jerie P
Cardiol J; 2016; 23(1):3-11. PubMed ID: 26412599
[TBL] [Abstract][Full Text] [Related]
17. Smoothing the Bumpy Road to Antiarrhythmic Drug Development.
Robinson VM; Kowey PR
Circulation; 2015 Dec; 132(23):2195-7. PubMed ID: 26499961
[No Abstract] [Full Text] [Related]
18. Atrial fibrillation: rate versus rhythm control.
Amani F; Smith ES
J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
[No Abstract] [Full Text] [Related]
19. Atrial fibrillation: pharmacological therapy.
Patel C; Salahuddin M; Jones A; Patel A; Yan GX; Kowey PR
Curr Probl Cardiol; 2011 Mar; 36(3):87-120. PubMed ID: 21392636
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive insight of novel antioxidant therapies for atrial fibrillation management.
Orenes-Piñero E; Valdés M; Lip GY; Marín F
Drug Metab Rev; 2015 Aug; 47(3):388-400. PubMed ID: 27412960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
